Violet Shen

1.8k total citations
34 papers, 1.2k citations indexed

About

Violet Shen is a scholar working on Hematology, Genetics and Neurology. According to data from OpenAlex, Violet Shen has authored 34 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Hematology, 10 papers in Genetics and 10 papers in Neurology. Recurrent topics in Violet Shen's work include Neuroblastoma Research and Treatments (9 papers), Childhood Cancer Survivors' Quality of Life (7 papers) and Glioma Diagnosis and Treatment (6 papers). Violet Shen is often cited by papers focused on Neuroblastoma Research and Treatments (9 papers), Childhood Cancer Survivors' Quality of Life (7 papers) and Glioma Diagnosis and Treatment (6 papers). Violet Shen collaborates with scholars based in United States, United Kingdom and Switzerland. Violet Shen's co-authors include Sima Jeha, Richard Kadota, Peter G. Steinherz, Paul S. Gaynon, Carmella van de Ven, Michael Rytting, S. Shenoy, David Irwin, H. Kantarjian and Bruce M. Camitta and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Clinical Cancer Research.

In The Last Decade

Violet Shen

34 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Violet Shen United States	17	424	340	285	277	277	34	1.2k
Brijesh Arora India	17	246 0.6×	266 0.8×	205 0.7×	178 0.6×	226 0.8×	67	1.0k
F Deméocq France	22	564 1.3×	424 1.2×	202 0.7×	204 0.7×	382 1.4×	78	1.5k
Erin Morris United States	22	224 0.5×	252 0.7×	389 1.4×	325 1.2×	400 1.4×	61	1.3k
L. de Lumley France	20	300 0.7×	270 0.8×	173 0.6×	176 0.6×	266 1.0×	45	1.0k
Ann Leahey United States	21	311 0.7×	186 0.5×	331 1.2×	160 0.6×	262 0.9×	38	1.7k
Amy Heerema‐McKenney United States	18	357 0.8×	320 0.9×	211 0.7×	253 0.9×	208 0.8×	42	1.3k
Ram Kumar Marwaha India	17	342 0.8×	192 0.6×	102 0.4×	180 0.6×	188 0.7×	73	904
Michael L. Graham United States	15	781 1.8×	144 0.4×	199 0.7×	200 0.7×	201 0.7×	32	1.3k
Ayad Atra United Kingdom	16	309 0.7×	236 0.7×	260 0.9×	122 0.4×	97 0.4×	48	820
Martine Münzer France	18	181 0.4×	264 0.8×	188 0.7×	142 0.5×	283 1.0×	43	1.0k

Countries citing papers authored by Violet Shen

Since Specialization

Citations

This map shows the geographic impact of Violet Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Violet Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Violet Shen more than expected).

Fields of papers citing papers by Violet Shen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Violet Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Violet Shen. The network helps show where Violet Shen may publish in the future.

Co-authorship network of co-authors of Violet Shen

This figure shows the co-authorship network connecting the top 25 collaborators of Violet Shen. A scholar is included among the top collaborators of Violet Shen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Violet Shen. Violet Shen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wilford, Justin, et al.. (2020). A Multi-Modal Family Peer Support-Based Program to Improve Quality of Life among Pediatric Brain Tumor Patients: A Mixed-Methods Pilot Study. Children. 7(4). 35–35. 3 indexed citations

Kieran, Mark W., Birgit Geoerger, Ira J. Dunkel, et al.. (2019). A Phase I and Pharmacokinetic Study of Oral Dabrafenib in Children and Adolescent Patients with Recurrent or Refractory BRAF V600 Mutation–Positive Solid Tumors. Clinical Cancer Research. 25(24). 7294–7302. 58 indexed citations

Buchbinder, David, Michelle A. Fortier, Kathryn Osann, et al.. (2017). Quality of Life Among Parents of Adolescent and Young Adult Brain Tumor Survivors. Journal of Pediatric Hematology/Oncology. 39(8). 579–584. 15 indexed citations

Hijiya, Nobuko, Blythe Thomson, Michael S. Isakoff, et al.. (2011). Phase 2 trial of clofarabine in combination with etoposide and cyclophosphamide in pediatric patients with refractory or relapsed acute lymphoblastic leukemia. Blood. 118(23). 6043–6049. 89 indexed citations

Hijiya, Nobuko, Paul S. Gaynon, Elly Barry, et al.. (2009). A multi-center phase I study of clofarabine, etoposide and cyclophosphamide in combination in pediatric patients with refractory or relapsed acute leukemia. Leukemia. 23(12). 2259–2264. 59 indexed citations

Jeha, Sima, Paul S. Gaynon, Bassem I. Razzouk, et al.. (2006). Phase II Study of Clofarabine in Pediatric Patients With Refractory or Relapsed Acute Lymphoblastic Leukemia. Journal of Clinical Oncology. 24(12). 1917–1923. 215 indexed citations

Blaney, Martha, et al.. (2006). Alteplase for the Treatment of Central Venous Catheter Occlusion in Children: Results of a Prospective, Open-label, Single-arm Study (The Cathflo Activase Pediatric Study). Journal of Vascular and Interventional Radiology. 17(11). 1745–1751. 32 indexed citations

Cairo, Mitchell S., Virginia Davenport, Olga Bessmertny, et al.. (2004). Phase I/II dose escalation study of recombinant human interleukin‐11 following ifosfamide, carboplatin and etoposide in children, adolescents and young adults with solid tumours or lymphoma: a clinical, haematological and biological study*. British Journal of Haematology. 128(1). 49–58. 22 indexed citations

Jeha, Sima, H. Kantarjian, David Irwin, et al.. (2004). Efficacy and safety of rasburicase, a recombinant urate oxidase (Elitek™), in the management of malignancy-associated hyperuricemia in pediatric and adult patients: final results of a multicenter compassionate use trial. Leukemia. 19(1). 34–38. 118 indexed citations

10.

Jeha, Sima, Bassem I. Razzouk, Michael Rytting, et al.. (2004). Phase II Trials of Clofarabine in Relapsed or Refractory Pediatric Leukemia.. Blood. 104(11). 684–684. 9 indexed citations

11.

Shen, Violet, et al.. (2003). Recombinant Tissue Plasminogen Activator (Alteplase) for Restoration of Function to Occluded Central Venous Catheters in Pediatric Patients. Journal of Pediatric Hematology/Oncology. 25(1). 38–45. 35 indexed citations

12.

Jennings, Mark T., Richard Sposto, James M. Boyett, et al.. (2002). Preradiation Chemotherapy in Primary High-Risk Brainstem Tumors: Phase II Study CCG-9941 of the Children’s Cancer Group. Journal of Clinical Oncology. 20(16). 3431–3437. 70 indexed citations

13.

Cairo, Mitchell S., Violet Shen, Mark Krailo, et al.. (2001). Prospective Randomized Trial Between Two Doses of Granulocyte Colony-Stimulating Factor After Ifosfamide, Carboplatin, and Etoposide in Children With Recurrent or Refractory Solid Tumors: A Children's Cancer Group Report. The American journal of pediatric hematology/oncology. 23(1). 30–38. 45 indexed citations

14.

Goldman, Stanton, Francisco Bracho, Virginia Davenport, et al.. (2001). Feasibility Study of IL-11 and Granulocyte Colony-Stimulating Factor After Myelosuppressive Chemotherapy to Mobilize Peripheral Blood Stem Cells From Heavily Pretreated Patients. The American journal of pediatric hematology/oncology. 23(5). 300–305. 11 indexed citations

15.

Houtenbos, Ilse, Francisco Bracho, Virginia Davenport, et al.. (2001). Autologous bone marrow transplantation for childhood acute lymphoblastic leukemia: a novel combined approach consisting of ex vivo marrow purging, modulation of multi-drug resistance, induction of autograft vs leukemia effect, and post-transplant immuno- and chemotherapy (PTIC). Bone Marrow Transplantation. 27(2). 145–153. 11 indexed citations

16.

Bracho, Francisco, Mark Krailo, Violet Shen, et al.. (2001). A phase I clinical, pharmacological, and biological trial of interleukin 6 plus granulocyte-colony stimulating factor after ifosfamide, carboplatin, and etoposide in children with recurrent/refractory solid tumors: enhanced hematological responses but a high incidence of grade III/IV constitutional toxicities.. PubMed. 7(1). 58–67. 13 indexed citations

17.

Shen, Violet, et al.. (1997). Collection and use of peripheral blood stem cells in young children with refractory solid tumors. Bone Marrow Transplantation. 19(3). 197–204. 15 indexed citations

18.

Packer, Roger J., Jill P. Ginsberg, Stephen J. Thompson, et al.. (1997). Acute Neurologic Dysfunction Associated with High-Dose Chemotherapy and Autologous Bone Marrow Rescue for Primary Malignant Brain Tumors. Pediatric Neurosurgery. 27(5). 230–237. 16 indexed citations

19.

Young, Ronald F., et al.. (1993). Multiple Spinal Meningiomas. Neurosurgery. 32(2). 298–302. 11 indexed citations

20.

Shen, Violet, et al.. (1990). Absence of isochromosome 12p in a pineal region malignant germ cell tumor. Cancer Genetics and Cytogenetics. 50(1). 153–160. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact